ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors
- PMID: 26228782
- PMCID: PMC4520720
- DOI: 10.3747/pdi.2014.00279
ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors
Abstract
Cardiovascular disease contributes significantly to the adverse clinical outcomes of peritoneal dialysis (PD) patients. Numerous cardiovascular risk factors play important roles in the development of various cardiovascular complications. Of these, loss of residual renal function is regarded as one of the key cardiovascular risk factors and is associated with an increased mortality and cardiovascular death. It is also recognized that PD solutions may incur significant adverse metabolic effects in PD patients. The International Society for Peritoneal Dialysis (ISPD) commissioned a global workgroup in 2012 to formulate a series of recommendations regarding lifestyle modification, assessment and management of various cardiovascular risk factors, as well as management of the various cardiovascular complications including coronary artery disease, heart failure, arrhythmia (specifically atrial fibrillation), cerebrovascular disease, peripheral arterial disease and sudden cardiac death, to be published in 2 guideline documents. This publication forms the first part of the guideline documents and includes recommendations on assessment and management of various cardiovascular risk factors. The documents are intended to serve as a global clinical practice guideline for clinicians who look after PD patients. The ISPD workgroup also identifies areas where evidence is lacking and further research is needed.
Keywords: Cardiovascular risk; anemia; dialysate calcium; dyslipidemia; glycosylated hemoglobin; hypertension; hypokalemia; inflammation; obesity; peritoneal dialysis; residual renal function; salt; volume.
Copyright © 2015 International Society for Peritoneal Dialysis.
Comment in
-
The ISPD Cardiovascular and Metabolic Guideline for Adults Treated with Peritoneal Dialysis.Perit Dial Int. 2015 Jul-Aug;35(4):377. doi: 10.3747/pdi.2015.00114. Perit Dial Int. 2015. PMID: 26228780 Free PMC article. No abstract available.
References
-
- Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012; 59:A7, e1–420. - PubMed
-
- de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302:1782–9. - PubMed
-
- Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int 2006; 69:1726–32. - PubMed
-
- Holmes CJ. Glucotoxicity in peritoneal dialysis-solutions for the solution! Adv Chronic Kidney Dis 2007; 14:269–78. - PubMed
-
- Paniagua R, Ventura MD, Avila-Díaz M, Hinojosa-Heredia H, Méndez-Durán A, Cueto-Manzano A, et al. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant 2010; 25:551–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
